Poland· PL-100224794
Karbis
A candesartan product containing candesartanum cilexetili, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Candesartan is registered in 16 of 19 countries.
Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Candesartan · ATC C09CA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of candesartan costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Candesartan · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- ES Spain$0.21
- IT Italy$0.15
The record
At a glance
URPL (Poland)- Active substance
- Candesartanum cilexetili
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- C09CA06
- ATC class
- Candesartan
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
2 priced- gtin05909990772155
- gtin0590999077217956 szt.PLN 26.02
- gtin0590999077216228 szt.PLN 14.51
- gtin05909991136581
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for candesartan.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09CA06
Candesartan, as other registers publish it.
- CanadaACH-CANDESARTANACCORD HEALTHCARE INC
- CanadaACH-CANDESARTANACCORD HEALTHCARE INC
- CanadaACH-CANDESARTANACCORD HEALTHCARE INC
- CanadaAG-CANDESARTAN TABLETSANGITA PHARMA INC.
- CanadaAG-CANDESARTAN TABLETSANGITA PHARMA INC.
- CanadaAG-CANDESARTAN TABLETSANGITA PHARMA INC.
- FinlandAmiasOrifarm Oy
- FinlandAmiasOrifarm Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5450ce9-79d9-44c2-8963-c8d99ea32b16 GET /v1/drugs/e5450ce9-79d9-44c2-8963-c8d99ea32b16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "8 mg",
"packaging": "05909990772155 ¦ Rp ¦ 57130\n14 tabl.\n05909990772162 ¦ Rp ¦ 57131\n28 tabl.\n05909990772179 ¦ Rp ¦ 57132\n56 tabl.\n05909991136581 ¦ Rp ¦ 91024\n84 tabl.",
"substance": "Candesartanum cilexetili 8 mg",
"common_name": "Candesartanum cilexetili",
"pl_product_id": "100224794",
"pozwolenie_nr": "16632",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about candesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.